108 related articles for article (PubMed ID: 37254544)
1. UBR5 Significantly Correlates with Osteosarcomas Prognosis and Immune Exhaustion Characteristic in the Tumor Microenvironment.
Lin H; Zhang L; Liu B; Cui G
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37254544
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y
Pathol Oncol Res; 2022; 28():1610396. PubMed ID: 36388433
[No Abstract] [Full Text] [Related]
3. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
4. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
5. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract][Full Text] [Related]
6. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
7. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
8. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
[TBL] [Abstract][Full Text] [Related]
9. UBR5 oncogene as an indicator of poor prognosis in gastric cancer.
Ding F; Zhu X; Song X; Yuan P; Ren L; Chai C; Zhou W; Li X
Exp Ther Med; 2020 Nov; 20(5):7. PubMed ID: 32934672
[TBL] [Abstract][Full Text] [Related]
10. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
[TBL] [Abstract][Full Text] [Related]
11. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
Int J Surg; 2024 May; ():. PubMed ID: 38701508
[TBL] [Abstract][Full Text] [Related]
12. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
13. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
Gu YF; Ge XP
J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
[TBL] [Abstract][Full Text] [Related]
14. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
15. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
16. UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway.
Wang K; Tang J; Liu X; Wang Y; Chen W; Zheng R
Oncol Rep; 2020 Aug; 44(2):685-697. PubMed ID: 32468011
[TBL] [Abstract][Full Text] [Related]
17. Circ-UBR5: An exonic circular RNA and novel small nuclear RNA involved in RNA splicing.
Qin M; Wei G; Sun X
Biochem Biophys Res Commun; 2018 Sep; 503(2):1027-1034. PubMed ID: 29944885
[TBL] [Abstract][Full Text] [Related]
18. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
20. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
